Atara Biotherapeutics: Q4 Earnings Insights

Atara Biotherapeutics ATRA reported its Q4 earnings results on Thursday, March 28, 2024 at 08:30 AM.

Here's what investors need to know about the announcement.

Atara Biotherapeutics missed estimated earnings by -17.0%, reporting an EPS of $-0.56 versus an estimate of $-0.48.

Revenue was up $4.03 million from the same period last year.

Last quarter the company missed on EPS by $0.0 which was followed by a 6.0% drop in the share price the next day.

Here's a look at Atara Biotherapeutics's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023
EPS Estimate	-0.66	-0.67	-0.39
EPS Actual	-0.66	-0.68	-0.72
Revenue Estimate	4.76M	3.77M	30.68M
Revenue Actual	2.14M	957K	1.23M

To track all earnings releases for Atara Biotherapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar